These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 37779532

  • 1. Rapid increases in epinephrine concentration following presumed intra-blood vessel administration via epinephrine autoinjector.
    Ebisawa M, Kaliner MA, Lowenthal R, Tanimoto S.
    J Allergy Clin Immunol Glob; 2023 Aug; 2(3):100118. PubMed ID: 37779532
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection.
    Casale TB, Ellis AK, Nowak-Wegrzyn A, Kaliner M, Lowenthal R, Tanimoto S.
    J Allergy Clin Immunol; 2023 Dec; 152(6):1587-1596. PubMed ID: 37604314
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector.
    Dworaczyk DA, Hunt AL, Di Spirito M, Lor M, Dretchen KL, Lamson MJ, Pollock J, Ward T.
    J Allergy Clin Immunol Glob; 2024 May; 3(2):100200. PubMed ID: 38328805
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bioavailability of epinephrine from Auvi-Q compared with EpiPen.
    Edwards ES, Gunn R, Simons ER, Carr K, Chinchilli VM, Painter G, Goldwater R.
    Ann Allergy Asthma Immunol; 2013 Aug; 111(2):132-7. PubMed ID: 23886232
    [Abstract] [Full Text] [Related]

  • 10. Development of neffy, an Epinephrine Nasal Spray, for Severe Allergic Reactions.
    Ellis AK, Casale TB, Kaliner M, Oppenheimer J, Spergel JM, Fleischer DM, Bernstein D, Camargo CA, Lowenthal R, Tanimoto S.
    Pharmaceutics; 2024 Jun 14; 16(6):. PubMed ID: 38931932
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement.
    Salter SM, Loh R, Sanfilippo FM, Clifford RM.
    Allergy Asthma Clin Immunol; 2014 Jun 14; 10(1):49. PubMed ID: 25264449
    [Abstract] [Full Text] [Related]

  • 13. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen).
    Gold MS, Sainsbury R.
    J Allergy Clin Immunol; 2000 Jul 14; 106(1 Pt 1):171-6. PubMed ID: 10887321
    [Abstract] [Full Text] [Related]

  • 14. Epinephrine in the Management of Anaphylaxis.
    Brown JC, Simons E, Rudders SA.
    J Allergy Clin Immunol Pract; 2020 Apr 14; 8(4):1186-1195. PubMed ID: 32276687
    [Abstract] [Full Text] [Related]

  • 15. Patient Carrying Time, Confidence, and Training with Epinephrine Autoinjectors: The RACE Survey.
    Portnoy J, Wade RL, Kessler C.
    J Allergy Clin Immunol Pract; 2019 Apr 14; 7(7):2252-2261. PubMed ID: 30922991
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intelliject's novel epinephrine autoinjector: sharps injury prevention validation and comparable analysis with EpiPen and Twinject.
    Guerlain S, Wang L, Hugine A.
    Ann Allergy Asthma Immunol; 2010 Dec 14; 105(6):480-4. PubMed ID: 21130387
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.